Innovative Medicines Initiative projects focused on translational safety have developed a range of tools to improve preclinical assessments of potential drug toxicities, and demonstrated the value of integrating data from multiple companies.
- Salah-Dine Chibout
- Dominique Brees
- Elisabetta Vaudano